| 1 |
34418731 | Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy. | 2021 Nov |
3 |
| 2 |
34439204 | LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models. | 2021 Aug 11 |
1 |
| 3 |
30390553 | Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. | 2019 Mar |
2 |
| 4 |
31075528 | Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer. | 2019 Jul |
4 |
| 5 |
30198004 | Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose) Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions. | 2018 Aug 31 |
2 |
| 6 |
27415012 | ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells. | 2016 Aug 9 |
5 |
| 7 |
24700236 | PARP Inhibitors as P-glyoprotein Substrates. | 2014 Jun |
1 |